Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Abbott to Buy Visiogen for $400M - Medical Product Outsourcing

Abbott to Buy Visiogen for $400M

The acquisition will help boost Abbott's vision care business.

Abbott Laboratories will purchase Visiogen Inc. for $400 million to help expand its vision care business, according to the Abbott Park, Ill.-based firm.

“This acquisition demonstrates Abbott’s continued commitment to vision care and our desire to introduce and accelerate technologies that have the ability to make a difference in the lives of millions of people around the world,” said John Capek, Abbott’s executive vice president of medical devices. Abbott entered the vision care market after acquiring Advanced Medical Optics in February.

Irvine, Calif.-based Visiogen brings an intraocular lens technology, called Synchrony, which addresses presbyopia for cataract patients.

Presbyopia is a condition in which the eye gradually loses its ability to focus on nearby objects. Intraocular lenses are implanted in a patient’s eye after the removal of the natural lens that has become clouded by a cataract. Visiogen’s Synchrony is designed to deliver improved vision at all distances.

Abbot said the deal should close in the fourth quarter of this year.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters